$BMMJ
BODY & MIND INC. Stock $bmmj

$bmmj Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000164033424000994 Filed on June 20, 2024

Income Statement

Concept	2024 Q2
Revenue	$4.406M
YoY Change	-39.75%
Cost Of Revenue	$2.442M
YoY Change	-53.36%
Gross Profit	$1.964M
YoY Change	-5.43%
Gross Profit Margin	44.58%
Selling, General & Admin	$3.209M
YoY Change	6.49%
% of Gross Profit	163.39%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$159.0K
YoY Change	-54.74%
% of Gross Profit	8.09%
Operating Expenses	-$3.303M
YoY Change	-10.84%
Operating Profit	-$1.339M
YoY Change	-17.75%
Interest Expense	-$141.6K
YoY Change	-69.72%
% of Operating Profit
Other Income/Expense, Net	$974.2K
YoY Change	2.25%
Pretax Income	-$2.161M
YoY Change	-19.04%
Income Tax	$388.4K
% Of Pretax Income
Net Earnings	-$2.538M
YoY Change	-29.67%
Net Earnings / Revenue	-57.61%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.02
COMMON SHARES
Basic Shares Outstanding	147.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$291.5K
YoY Change	-89.06%
Cash & Equivalents	$291.5K
Short-Term Investments
Other Short-Term Assets	$1.538M
YoY Change	104.75%
Inventory	$632.6K
Prepaid Expenses	$571.1K
Receivables	$41.93K
Other Receivables	$100.0K
Total Short-Term Assets	$4.696M
YoY Change	-34.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.606M
YoY Change	-69.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.035M
YoY Change	1948.75%
Total Long-Term Assets	$11.49M
YoY Change	-54.77%
TOTAL ASSETS
Total Short-Term Assets	$4.696M
Total Long-Term Assets	$11.49M
Total Assets	$16.19M
YoY Change	-50.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.344M
YoY Change	-12.92%
Accrued Expenses	$297.0K
YoY Change	-6.78%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$493.3K
YoY Change	1621.32%
Total Short-Term Liabilities	$10.11M
YoY Change	-5.99%
LONG-TERM LIABILITIES
Long-Term Debt	$4.869M
YoY Change	-52.34%
Other Long-Term Liabilities	$13.14M
YoY Change	35.17%
Total Long-Term Liabilities	$18.01M
YoY Change	-9.67%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.11M
Total Long-Term Liabilities	$18.01M
Total Liabilities	$28.12M
YoY Change	-9.39%
SHAREHOLDERS EQUITY
Retained Earnings	-$69.60M
YoY Change	25.48%
Common Stock	$14.77K
YoY Change	0.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$13.09M
YoY Change
Total Liabilities & Shareholders Equity	$16.19M
YoY Change	-50.36%

Cashflow Statement

Concept	2024 Q2
OPERATING ACTIVITIES
Net Income	-$2.538M
YoY Change	-29.67%
Depreciation, Depletion And Amortization	$159.0K
YoY Change	-54.74%
Cash From Operating Activities	-$1.358M
YoY Change	-609.04%
INVESTING ACTIVITIES
Capital Expenditures	$0.00
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$38.91K
YoY Change	-82.33%
Cash From Investing Activities	$38.91K
YoY Change	-105.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	6.960K
YoY Change	-120.72%
NET CHANGE
Cash From Operating Activities	-1.358M
Cash From Investing Activities	38.91K
Cash From Financing Activities	6.960K
Net Change In Cash	-1.312M
YoY Change	150.21%
FREE CASH FLOW
Cash From Operating Activities	-$1.358M
Capital Expenditures	$0.00
Free Cash Flow	-$1.358M
YoY Change	90.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	147686393	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	146636974	shares
	dei	Entity Central Index Key EntityCentralIndexKey	0001715611
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--07-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Address State Or Province EntityAddressStateOrProvince	BC
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	146636974	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	147686393	shares
	bmmj	Other Overheadexpenses OtherOverheadexpenses	1250000	usd
	bmmj	Expected Life Of The Options ExpectedLifeOfTheOptions	P1Y8M12D
CY2024Q2	us-gaap	Unsecured Debt UnsecuredDebt	0	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-04-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-55940
	dei	Entity Registrant Name EntityRegistrantName	BODY AND MIND INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1319227
	dei	Entity Address Address Line1 EntityAddressAddressLine1	750 – 1095 West Pender Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	Vancouver
	dei	Entity Address Country EntityAddressCountry	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	V6E 2M6
	dei	City Area Code CityAreaCode	800
	dei	Local Phone Number LocalPhoneNumber	361-6312
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	147686393	shares
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	291543	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1460311	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	41932	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	27234	usd
CY2024Q2	us-gaap	Other Receivables OtherReceivables	1850000	usd
CY2023Q3	us-gaap	Other Receivables OtherReceivables	0	usd
CY2024Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	342000	usd
CY2023Q3	us-gaap	Interest Receivable Current InterestReceivableCurrent	294000	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	571108	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	448341	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	632594	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	909875	usd
CY2024Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	966835	usd
CY2023Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	6290210	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	4696012	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	9429971	usd
CY2024Q2	us-gaap	Deposit Assets DepositAssets	1035026	usd
CY2023Q3	us-gaap	Deposit Assets DepositAssets	72617	usd
CY2024Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1250000	usd
CY2023Q3	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1700411	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1606266	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1827215	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4028355	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4329634	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3571716	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3849932	usd
CY2024Q2	us-gaap	Assets Assets	16187375	usd
CY2023Q3	us-gaap	Assets Assets	21209780	usd
CY2024Q2	us-gaap	Bank Overdrafts BankOverdrafts	0	usd
CY2023Q3	us-gaap	Bank Overdrafts BankOverdrafts	509937	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3343575	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2499181	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	296976	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	462025	usd
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	2768351	usd
CY2023Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	1758267	usd
CY2024Q2	bmmj	Due To Related Party Current DueToRelatedPartyCurrent	87966	usd
CY2023Q3	bmmj	Due To Related Party Current DueToRelatedPartyCurrent	93481	usd
CY2024Q2	us-gaap	Loans Payable Current LoansPayableCurrent	493333	usd
CY2023Q3	us-gaap	Loans Payable Current LoansPayableCurrent	166001	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	928195	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	980265	usd
CY2024Q2	us-gaap	Disposal Group Including Discontinued Operation Other Current Liabilities DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities	2188623	usd
CY2023Q3	us-gaap	Disposal Group Including Discontinued Operation Other Current Liabilities DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities	2260953	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	10107019	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	8730110	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5968844	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6801711	usd
CY2024Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	2300000	usd
CY2023Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	7779659	usd
CY2024Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	2569427	usd
CY2023Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	2480522	usd
CY2024Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	7173713	usd
CY2023Q3	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	4757387	usd
CY2024Q2	us-gaap	Liabilities Liabilities	28119003	usd
CY2023Q3	us-gaap	Liabilities Liabilities	30549389	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	14768	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	14663	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55338820	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55057531	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1152329	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1482567	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-69596086	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-66829507	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-13090169	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-10274746	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	1158541	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	935137	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-11931628	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9339609	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16187375	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21209780	usd
CY2024Q2	us-gaap	Revenues Revenues	4406132	usd
CY2023Q2	us-gaap	Revenues Revenues	4171339	usd
	us-gaap	Revenues Revenues	13393018	usd
	us-gaap	Revenues Revenues	13237458	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	2441826	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	2244898	usd
	us-gaap	Cost Of Revenue CostOfRevenue	7338477	usd
	us-gaap	Cost Of Revenue CostOfRevenue	7811513	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	1964306	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1926441	usd
	us-gaap	Gross Profit GrossProfit	6054541	usd
	us-gaap	Gross Profit GrossProfit	5425945	usd
CY2024Q2	us-gaap	Legal Fees LegalFees	428556	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	199558	usd
	us-gaap	Legal Fees LegalFees	1058957	usd
	us-gaap	Legal Fees LegalFees	863227	usd
CY2024Q2	us-gaap	Business Development BusinessDevelopment	199071	usd
CY2023Q2	us-gaap	Business Development BusinessDevelopment	340106	usd
	us-gaap	Business Development BusinessDevelopment	201830	usd
	us-gaap	Business Development BusinessDevelopment	754364	usd
CY2024Q2	us-gaap	Professional Fees ProfessionalFees	346025	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	99553	usd
	us-gaap	Professional Fees ProfessionalFees	805907	usd
	us-gaap	Professional Fees ProfessionalFees	502920	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	93952	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	261013	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	286033	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	800635	usd
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	316250	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	371215	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	823869	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	868869	usd
CY2024Q2	us-gaap	Other Expenses OtherExpenses	974202	usd
CY2023Q2	us-gaap	Other Expenses OtherExpenses	848968	usd
	us-gaap	Other Expenses OtherExpenses	3110478	usd
	us-gaap	Other Expenses OtherExpenses	2542463	usd
CY2024Q2	us-gaap	Management Fee Expense ManagementFeeExpense	93883	usd
CY2023Q2	us-gaap	Management Fee Expense ManagementFeeExpense	100195	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	323945	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	304152	usd
CY2024Q2	us-gaap	Salaries And Wages SalariesAndWages	851405	usd
CY2023Q2	us-gaap	Salaries And Wages SalariesAndWages	988387	usd
	us-gaap	Salaries And Wages SalariesAndWages	2699342	usd
	us-gaap	Salaries And Wages SalariesAndWages	2614555	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	-3303344	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	-3208995	usd
	us-gaap	Operating Expenses OperatingExpenses	-9310361	usd
	us-gaap	Operating Expenses OperatingExpenses	-9251185	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1339038	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1282554	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3255820	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3825240	usd
CY2024Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	16	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1153	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1252	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1013	usd
CY2024Q2	bmmj	Gain Loss On Fair Value Adjustment Of Convertible Loan GainLossOnFairValueAdjustmentOfConvertibleLoan	-659834	usd
CY2023Q2	bmmj	Gain Loss On Fair Value Adjustment Of Convertible Loan GainLossOnFairValueAdjustmentOfConvertibleLoan	359088	usd
	bmmj	Gain Loss On Fair Value Adjustment Of Convertible Loan GainLossOnFairValueAdjustmentOfConvertibleLoan	-450411	usd
	bmmj	Gain Loss On Fair Value Adjustment Of Convertible Loan GainLossOnFairValueAdjustmentOfConvertibleLoan	359088	usd
CY2024Q2	us-gaap	Interest Expense Other InterestExpenseOther	153620	usd
CY2023Q2	us-gaap	Interest Expense Other InterestExpenseOther	483247	usd
	us-gaap	Interest Expense Other InterestExpenseOther	2224725	usd
	us-gaap	Interest Expense Other InterestExpenseOther	1288907	usd
CY2024Q2	us-gaap	Interest Income Other InterestIncomeOther	12000	usd
CY2023Q2	us-gaap	Interest Income Other InterestIncomeOther	18000	usd
	us-gaap	Interest Income Other InterestIncomeOther	48000	usd
	us-gaap	Interest Income Other InterestIncomeOther	54000	usd
CY2024Q2	bmmj	Loss On Settlement Of Related Party Liability LossOnSettlementOfRelatedPartyLiability	30700	usd
CY2023Q2	bmmj	Loss On Settlement Of Related Party Liability LossOnSettlementOfRelatedPartyLiability	0	usd
	bmmj	Loss On Settlement Of Related Party Liability LossOnSettlementOfRelatedPartyLiability	30700	usd
	bmmj	Loss On Settlement Of Related Party Liability LossOnSettlementOfRelatedPartyLiability	0	usd
CY2024Q2	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	0	usd
CY2023Q2	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	0	usd
	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-124649	usd
	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	0	usd
CY2024Q2	us-gaap	Other Income OtherIncome	9826	usd
CY2023Q2	us-gaap	Other Income OtherIncome	10800	usd
	us-gaap	Other Income OtherIncome	25829	usd
	us-gaap	Other Income OtherIncome	70488	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-822312	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-96512	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2757908	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-804318	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2161350	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1379066	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6013728	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4629558	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	388351	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	449397	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1751866	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1196343	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2549701	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1828463	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-7765594	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-5825901	usd
CY2024Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	11511	usd
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1780309	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1124629	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-3476714	usd
CY2024Q2	bmmj	Gain On Sale Of Nmg Oh1 Llc Net Of Tax GainOnSaleOfNmgOh1LlcNetOfTax	0	usd
CY2023Q2	bmmj	Gain On Sale Of Nmg Oh1 Llc Net Of Tax GainOnSaleOfNmgOh1LlcNetOfTax	0	usd
	bmmj	Gain On Sale Of Nmg Oh1 Llc Net Of Tax GainOnSaleOfNmgOh1LlcNetOfTax	4058665	usd
	bmmj	Gain On Sale Of Nmg Oh1 Llc Net Of Tax GainOnSaleOfNmgOh1LlcNetOfTax	0	usd
CY2024Q2	bmmj	Gain On Sale Of Nmg Net Of Tax GainOnSaleOfNmgNetOfTax	0	usd
CY2023Q2	bmmj	Gain On Sale Of Nmg Net Of Tax GainOnSaleOfNmgNetOfTax	0	usd
	bmmj	Gain On Sale Of Nmg Net Of Tax GainOnSaleOfNmgNetOfTax	2288383	usd
	bmmj	Gain On Sale Of Nmg Net Of Tax GainOnSaleOfNmgNetOfTax	0	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2538190	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-3608772	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2543175	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9302615	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	148755	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	32315	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-330238	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-48087	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-2389435	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-3576457	usd
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-2873413	usd
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-9350702	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-2608402	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1978527	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-7988998	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-6183082	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	58701	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	150064	usd
	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	223404	usd
	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	357181	usd
CY2024Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-2596891	usd
CY2023Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-3758836	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-2766579	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-9659796	usd
CY2024Q2	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	58701	usd
CY2023Q2	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	150064	usd
	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	223404	usd
	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	357181	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2448136	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3726521	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3096817	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-9707883	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	58701	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	150064	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	223404	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	357181	usd
CY2024Q2	bmmj	Income Loss Per Basic And Diluted Share From Continuing Operations IncomeLossPerBasicAndDilutedShareFromContinuingOperations	-0.02
CY2023Q2	bmmj	Income Loss Per Basic And Diluted Share From Continuing Operations IncomeLossPerBasicAndDilutedShareFromContinuingOperations	-0.01
	bmmj	Income Loss Per Basic And Diluted Share From Continuing Operations IncomeLossPerBasicAndDilutedShareFromContinuingOperations	-0.05
	bmmj	Income Loss Per Basic And Diluted Share From Continuing Operations IncomeLossPerBasicAndDilutedShareFromContinuingOperations	-0.05
CY2024Q2	bmmj	Income Loss Per Basic And Diluted Share From Discontinued Operations Net Of Tax IncomeLossPerBasicAndDilutedShareFromDiscontinuedOperationsNetOfTax	0.00
CY2023Q2	bmmj	Income Loss Per Basic And Diluted Share From Discontinued Operations Net Of Tax IncomeLossPerBasicAndDilutedShareFromDiscontinuedOperationsNetOfTax	-0.01
	bmmj	Income Loss Per Basic And Diluted Share From Discontinued Operations Net Of Tax IncomeLossPerBasicAndDilutedShareFromDiscontinuedOperationsNetOfTax	0.04
	bmmj	Income Loss Per Basic And Diluted Share From Discontinued Operations Net Of Tax IncomeLossPerBasicAndDilutedShareFromDiscontinuedOperationsNetOfTax	-0.03
CY2024Q2	bmmj	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.02
CY2023Q2	bmmj	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.02
	bmmj	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.01
	bmmj	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.08
CY2024Q2	bmmj	Weightedaveragenumberofsharesissuedbasic Continuing Operations WeightedaveragenumberofsharesissuedbasicContinuingOperations	147416354	shares
CY2023Q2	bmmj	Weightedaveragenumberofsharesissuedbasic Continuing Operations WeightedaveragenumberofsharesissuedbasicContinuingOperations	146636974	shares
	bmmj	Weightedaveragenumberofsharesissuedbasic Continuing Operations WeightedaveragenumberofsharesissuedbasicContinuingOperations	146519397	shares
	bmmj	Weightedaveragenumberofsharesissuedbasic Continuing Operations WeightedaveragenumberofsharesissuedbasicContinuingOperations	130203817	shares
CY2024Q2	bmmj	Weightedaveragenumberofdilutedsharesoutstanding Continuing Operations WeightedaveragenumberofdilutedsharesoutstandingContinuingOperations	147416354	shares
CY2023Q2	bmmj	Weightedaveragenumberofdilutedsharesoutstanding Continuing Operations WeightedaveragenumberofdilutedsharesoutstandingContinuingOperations	146636974	shares
	bmmj	Weightedaveragenumberofdilutedsharesoutstanding Continuing Operations WeightedaveragenumberofdilutedsharesoutstandingContinuingOperations	146519397	shares
	bmmj	Weightedaveragenumberofdilutedsharesoutstanding Continuing Operations WeightedaveragenumberofdilutedsharesoutstandingContinuingOperations	130203817	shares
CY2024Q2	bmmj	Eighted Average Number Of Shares Outstanding Discontinuing Operations Basic eightedAverageNumberOfSharesOutstandingDiscontinuingOperationsBasic	147416354	shares
CY2023Q2	bmmj	Eighted Average Number Of Shares Outstanding Discontinuing Operations Basic eightedAverageNumberOfSharesOutstandingDiscontinuingOperationsBasic	146636974	shares
	bmmj	Eighted Average Number Of Shares Outstanding Discontinuing Operations Basic eightedAverageNumberOfSharesOutstandingDiscontinuingOperationsBasic	146519397	shares
	bmmj	Eighted Average Number Of Shares Outstanding Discontinuing Operations Basic eightedAverageNumberOfSharesOutstandingDiscontinuingOperationsBasic	130203817	shares
CY2024Q2	bmmj	Weightedaveragenumberofdilutedsharesoutstanding Discontinuingoperations WeightedaveragenumberofdilutedsharesoutstandingDiscontinuingoperations	147416354	shares
CY2023Q2	bmmj	Weightedaveragenumberofdilutedsharesoutstanding Discontinuingoperations WeightedaveragenumberofdilutedsharesoutstandingDiscontinuingoperations	146636974	shares
	bmmj	Weightedaveragenumberofdilutedsharesoutstanding Discontinuingoperations WeightedaveragenumberofdilutedsharesoutstandingDiscontinuingoperations	146519397	shares
	bmmj	Weightedaveragenumberofdilutedsharesoutstanding Discontinuingoperations WeightedaveragenumberofdilutedsharesoutstandingDiscontinuingoperations	130203817	shares
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9339609	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	35343	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-369202	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	163815	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9509653	usd
CY2024Q1	bmmj	Shares Returned To Treasury Related To Investment In Gldh Amount SharesReturnedToTreasuryRelatedToInvestmentInGldhAmount	0	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	18465	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-109791	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-168800	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9769779	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	210700	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	16886	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	148755	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-2538190	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-11931628	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10105419	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	32458	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-70060	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-2952795	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7115022	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	usd
CY2023Q1	bmmj	Common Stock Issued In Merger Of Craftedplants Nj Amount CommonStockIssuedInMergerOfCraftedplantsNjAmount	0	usd
CY2023Q1	bmmj	Debt Conversion Converted Instrument Warrants Or Options Issued1 Value DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1Value	592159	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	22013	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-10342	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2741050	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4977802	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	177642	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	32315	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-3608770	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1578989	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-7765594	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-5825901	usd
	bmmj	Accrued Interest And Accretion Expense AccruedInterestAndAccretionExpense	1275913	usd
	bmmj	Accrued Interest And Accretion Expense AccruedInterestAndAccretionExpense	601775	usd
	bmmj	Accrued Interest Income AccruedInterestIncome	48000	usd
	bmmj	Accrued Interest Income AccruedInterestIncome	54000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	278216	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	763846	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	301279	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	868869	usd
	us-gaap	Depreciation Depreciation	208120	usd
	us-gaap	Depreciation Depreciation	141055	usd
	bmmj	Loss Gain On Fair Value Adjustment Of Convertible Loan LossGainOnFairValueAdjustmentOfConvertibleLoan	450411	usd
	bmmj	Loss Gain On Fair Value Adjustment Of Convertible Loan LossGainOnFairValueAdjustmentOfConvertibleLoan	-359088	usd
	bmmj	Loss On Settlement Of Related Party Liability LossOnSettlementOfRelatedPartyLiability	30700	usd
	bmmj	Loss On Settlement Of Related Party Liability LossOnSettlementOfRelatedPartyLiability	0	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	124649	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	70694	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	232113	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	1987465	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	36306	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-277281	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	74936	usd
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-962409	usd
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	63309	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	833088	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1045327	usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	1648734	usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	2169993	usd
	bmmj	Increase Decrease In Due To Related Party IncreaseDecreaseInDueToRelatedParty	-5515	usd
	bmmj	Increase Decrease In Due To Related Party IncreaseDecreaseInDueToRelatedParty	-15523	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-884937	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-916207	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-6154835	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1395674	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	3906118	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-489798	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2248717	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1885472	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	111820	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	965046	usd
	bmmj	Net Proceeds From Loans Payable NetProceedsFromLoansPayable	345112	usd
	bmmj	Net Proceeds From Loans Payable NetProceedsFromLoansPayable	769180	usd
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	233292	usd
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-195866	usd
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	8297983	usd
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-36508	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	8531275	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-232374	usd
	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	-509937	usd
	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	0	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	6658190	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	22826	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7168127	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2977174	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-330238	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-48087	usd
	bmmj	Cash Transferred From Assets Held For Sale CashTransferredFromAssetsHeldForSale	47039	usd
	bmmj	Cash Transferred From Assets Held For Sale CashTransferredFromAssetsHeldForSale	256789	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1168768	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1068030	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1460311	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	291543	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1431697	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	291543	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2499727	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>1.Nature and Continuance of Operations</strong> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.25in; text-align:justify;">Body and Mind Inc. (the “Company”) was incorporated on 5 November 1998 in the State of Delaware, USA, under the name Concept Development Group, Inc. In May 2004, the Company acquired 100% of Vocalscape, Inc. and changed its name to Vocalscape, Inc. On October 28, 2005, the Company changed its name to Nevstar Precious Metals Inc. On October 23, 2008, the Company changed its name to Deploy Technologies Inc. (“Deploy Tech”) and, on September 15, 2010, the Company incorporated a wholly-owned subsidiary, Deploy Acquisition Corp. (“Deploy”) under the laws of the State of Nevada, USA. On September 17, 2010, the Company merged with and into Deploy under the laws of the State of Nevada. Deploy, as the surviving corporation of the merger, assumed all the assets, obligations and commitments of Deploy Tech, and we were effectively re-domiciled in the State of Nevada. Upon the completion of the merger, Deploy assumed the name “Deploy Technologies Inc.”, and all of the issued and outstanding common stock of Deploy Tech was automatically converted into and became Deploy’s issued and outstanding common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.25in; text-align:justify;">On 14 November 2017, the Company acquired Nevada Medical Group, LLC (“NMG”) and changed its name to Body and Mind Inc. The Company is now a supplier and grower of medical and recreational cannabis in the state of Nevada, and has retail operations in California, Ohio, Illinois and Arkansas (through March 15, 2024).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.25in; text-align:justify;"><strong><span style="text-decoration:underline">Principles of Consolidation</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.25in; text-align:justify;">These consolidated financial statements include the financial statements of the Company and its subsidiaries as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Name</strong></p></td><td style="width:2%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: #000000 1px solid;width:14%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Jurisdiction</strong></p></td><td style="width:2%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: #000000 1px solid;width:15%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Ownership</strong></p></td><td style="width:2%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: #000000 1px solid;width:17%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Date of acquisition or formation</strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">DEP Nevada Inc. (“DEP Nevada”)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Nevada, USA</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">100%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">10 August 2017</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">NMG Long Beach LLC (“NMG LB”)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">California, USA</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">100%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">18 December 2018</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">NMG San Diego LLC (“NMG SD”)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">California, USA</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">60%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">30 January 2019</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">NMG Ohio LLC (“NMG Ohio”)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> Ohio, USA</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">100%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">27 April 2017</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">NMG OH P1, LLC (“NMG OH P1”)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Ohio, USA</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">100%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">30 January 2020</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">NMG MI C1 Inc.</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Michigan, USA</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">100%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">24 June 2021</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">NMG MI P1 Inc.</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Michigan, USA</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">100%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">24 June 2021</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Canopy Monterey Bay, LLC (“Canopy”)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">California, USA</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">100%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">30 November 2021</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">NMG CA P1, LLC (“NMG CA P1”)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">California, USA</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">100%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">7 January 2020</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">NMG CA C1, LLC (“NMG CA C1”)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">California, USA</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">100%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">7 October 2020</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">BaM Body and Mind Dispensary NJ, Inc. (“BAM NJ”)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">New Jersey, USA</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">95%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">21 December 2022</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">NMG TX 1 LLC </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Texas, USA</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">100%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">22 March 2023</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">NMG IL4, LLC (“NMG IL 4”)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Illinois, USA</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">100%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">25 April 2023</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.25in; text-align:justify;">These consolidated financial statements include the Company’s wholly-owned subsidiaries of NMG MI 1, Inc. (“NMG MI 1”), NMG OH 1, LLC (“NMG OH 1”) and Nevada Medical Group LLC (“NMG”) up to the date of disposition on June 13, 2023, on October 17,2023 and on December 15, 2023, respectively (Note 21). Also see the Consolidated Variable Interest Entity accounting policy in Note 3.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.25in; text-align:justify;">All inter-company transactions and balances are eliminated upon consolidation.</p>
	bmmj	Schedule Of Property Plant And Equipment Useful Lives ScheduleOfPropertyPlantAndEquipmentUsefulLives	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td style="width:20%;vertical-align:top;">Office equipment </td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">7 years</p></td></tr><tr style="height:15px"><td style="vertical-align:top;">Cultivation equipment </td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">7 years</p></td></tr><tr style="height:15px"><td style="vertical-align:top;">Production equipment </td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">7 years</p></td></tr><tr style="height:15px"><td style="vertical-align:top;">Kitchen equipment</td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">7 years</p></td></tr><tr style="height:15px"><td style="vertical-align:top;">Vehicles</td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">7 years</p></td></tr><tr style="height:15px"><td style="vertical-align:top;">Vault equipment </td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">7 years</p></td></tr><tr style="height:15px"><td style="vertical-align:top;">Leasehold improvements </td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">shorter of useful life or the term of the lease</p></td></tr></tbody></table>
CY2024Q2	bmmj	Working Capital Deficit WorkingCapitalDeficit	-5411007	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15296000	shares
	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	20800000	shares
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.25in; text-align:justify;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosures of contingent assets and liabilities, if any, at the date of the consolidated financial statements and the reported amounts of revenues and expenditures during the reporting period. Actual results could differ from these estimates.</p>
CY2024Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	291543	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	1460311	usd
CY2024Q2	bmmj	Convertible Loan Receivable Fair Value Disclosure ConvertibleLoanReceivableFairValueDisclosure	1250000	usd
CY2023Q3	bmmj	Convertible Loan Receivable Fair Value Disclosure ConvertibleLoanReceivableFairValueDisclosure	1700411	usd
CY2024Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1541543	usd
CY2023Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	3160722	usd
CY2024Q2	us-gaap	Other Receivables OtherReceivables	1850000	usd
CY2023Q3	us-gaap	Other Receivables OtherReceivables	0	usd
CY2024Q2	us-gaap	Deposits Deposits	1035026	usd
CY2023Q3	us-gaap	Deposits Deposits	72617	usd
CY2024Q2	bmmj	Inventory Consumables InventoryConsumables	632594	usd
CY2023Q3	bmmj	Inventory Consumables InventoryConsumables	909875	usd
CY2024Q2	us-gaap	Inventory Gross InventoryGross	632594	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	909875	usd
CY2024Q2	bmmj	Loan Receivable LoanReceivable	1250000	usd
CY2023Q3	bmmj	Loan Receivable LoanReceivable	1250000	usd
CY2024Q2	bmmj	Accrued Interest Income Loss AccruedInterestIncomeLoss	12000	usd
CY2023Q2	bmmj	Accrued Interest Income Loss AccruedInterestIncomeLoss	18000	usd
	bmmj	Accrued Interest Income Loss AccruedInterestIncomeLoss	48000	usd
	bmmj	Accrued Interest Income Loss AccruedInterestIncomeLoss	54000	usd
CY2024Q2	us-gaap	Interest Receivable InterestReceivable	342000	usd
CY2023Q3	us-gaap	Interest Receivable InterestReceivable	294000	usd
	bmmj	Description Management Agreement Expiring Date DescriptionManagementAgreementExpiringDate	the right to an allocative share of sixty-six and 67/100 percent (66.67%) of the net profits of CCG and the right to distributions equal to sixty-six and 67/100 percent (66.67%) of the net profits on a monthly basis; (ii) the right to a sixty-six and 67/100 percent (66.67%) share of CCG’s assets upon dissolution of CCG; and (iii) the right to sixty-six and 67/100 percent (66.67%) of all voting rights of members of CCG. On or around September 18, 2023
	bmmj	Equity Price EquityPrice	75000	usd
CY2024Q2	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	1250000	usd
CY2023Q3	bmmj	Operating Cost Of Property Plant And Equipments OperatingCostOfPropertyPlantAndEquipments	2479453	usd
	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	111820	usd
	bmmj	Impairmentof Office Equipment ImpairmentofOfficeEquipment	-257737	usd
CY2024Q2	bmmj	Operating Cost Of Property Plant And Equipments OperatingCostOfPropertyPlantAndEquipments	2333536	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	652238	usd
	us-gaap	Depletion Depletion	208120	usd
	bmmj	Impairment Accumulated Depreciation ImpairmentAccumulatedDepreciation	-133088	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	727270	usd
	bmmj	Net Book Value Beginning Balance NetBookValueBeginningBalance	1827215	usd
	bmmj	Net Book Value Ending Balance NetBookValueEndingBalance	1606266	usd
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	7816	usd
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	36789	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	200304	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	104266	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	124649	usd
CY2021Q4	bmmj	Business Combination Consideration Transferred Promissory Note BusinessCombinationConsiderationTransferredPromissoryNote	2300000	usd
	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	16301694	shares
CY2022	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	503179	usd
CY2022	bmmj	Business Acquisitions Payment Of Consulting Fees BusinessAcquisitionsPaymentOfConsultingFees	100000	usd
CY2022Q4	bmmj	Lease Liability And Right Of Use Assets LeaseLiabilityAndRightOfUseAssets	170000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	278216	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	763846	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	93415	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	370616	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	370616	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	370616	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	371632	usd
CY2024Q2	bmmj	Finite Lived Intangible Assets Amortization Expense There After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseThereAfterYearFive	1774821	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3351716	usd
CY2024Q2	us-gaap	Payment For Management Fee PaymentForManagementFee	93883	usd
CY2023Q2	us-gaap	Payment For Management Fee PaymentForManagementFee	100195	usd
	us-gaap	Payment For Management Fee PaymentForManagementFee	323945	usd
	us-gaap	Payment For Management Fee PaymentForManagementFee	304152	usd
	bmmj	Commision Interest Percentage Rate CommisionInterestPercentageRate	0.025	pure
CY2024Q2	bmmj	Focusgrowth Loan FocusgrowthLoan	0	usd
CY2023Q3	bmmj	Focusgrowth Loan FocusgrowthLoan	6666667	usd
CY2024Q2	bmmj	Long Beach Loan LongBeachLoan	0	usd
CY2023Q3	bmmj	Long Beach Loan LongBeachLoan	10728	usd
CY2024Q2	bmmj	Ccg Loan CcgLoan	493333	usd
CY2023Q3	bmmj	Ccg Loan CcgLoan	148221	usd
CY2024Q2	bmmj	Secured Promissory Note SecuredPromissoryNote	2300000	usd
CY2023Q3	bmmj	Secured Promissory Note SecuredPromissoryNote	2300000	usd
CY2024Q2	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	0	usd
CY2023Q3	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	7052	usd
CY2024Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	2793333	usd
CY2023Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	9132668	usd
CY2024Q2	bmmj	Debt Instrument Discount DebtInstrumentDiscount	0	usd
CY2023Q3	bmmj	Debt Instrument Discount DebtInstrumentDiscount	-1187008	usd
CY2024Q2	bmmj	Outstanding Loan Balance OutstandingLoanBalance	2793333	usd
CY2023Q3	bmmj	Outstanding Loan Balance OutstandingLoanBalance	7945660	usd
CY2024Q2	us-gaap	Loans Payable Current LoansPayableCurrent	493333	usd
CY2023Q3	us-gaap	Loans Payable Current LoansPayableCurrent	166001	usd
CY2024Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	2300000	usd
CY2023Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	7779659	usd
CY2021Q3	bmmj	Origination Discount Rate OriginationDiscountRate	0.10	pure
	bmmj	Legal Fees And Other Fees LegalFeesAndOtherFees	175758	usd
	bmmj	Warrants Issued For Services Shares WarrantsIssuedForServicesShares	4800000	shares
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1037146	usd
	bmmj	Combined Fees CombinedFees	175758	usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	666667	usd
	bmmj	Debt Discount Loan DebtDiscountLoan	1883901	usd
CY2022Q2	bmmj	Description Of Second Amendment To The Loan Agreement DescriptionOfSecondAmendmentToTheLoanAgreement	the Company entered into a second amendment to the Loan Agreement (“Amendment No. 2 to Loan Agreement”) to extend the maturity date by one year to 19 July 2026. Additionally, Amendment No. 2 to Loan Agreement allows the outside date for the Company to draw on the delayed draw term loan of US$4.44 million to be extended from June 1, 2022 to March 31, 2023, whereby US$4 million in funds will be advanced to the Company. The ability of the Company to draw on the delayed draw term loan was subject to compliance with certain provisions in Loan Agreement including provision of a satisfactory budget approved at the sole discretion of the Lender. The Company did not draw or extend the Delayed Draw Term Loan and has expired
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	79585	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	7335722	usd
	bmmj	Principal Balance PrincipalBalance	6666666	usd
	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	326512	usd
	us-gaap	Payments To Acquire Projects PaymentsToAcquireProjects	342543	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	1415504	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1187008	usd
CY2023Q3	us-gaap	Unsecured Debt UnsecuredDebt	10728	usd
CY2021Q3	bmmj	Periodic Rent Payable Percentage PeriodicRentPayablePercentage	0.03	pure
CY2021Q3	bmmj	Periodic Rent Payable Amount PeriodicRentPayableAmount	9913	usd
	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	823869	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1470578	usd
	bmmj	Weighted Average Remaining Lease Term Operating Leases WeightedAverageRemainingLeaseTermOperatingLeases	P6Y2M23D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.12	pure
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	425024	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	1712955	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	1740745	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive	1469408	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	4650416	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	9998548	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3101509	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	6897039	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	928195	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5968844	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	bmmj	Issuance Of Aggregate Common Stock Shares IssuanceOfAggregateCommonStockShares	319149	shares
CY2024Q2	bmmj	Issuance Of Aggregate Common Stock Shares IssuanceOfAggregateCommonStockShares	16301694	shares
CY2022Q4	bmmj	Common Stcok Shares Held In Escrow CommonStcokSharesHeldInEscrow	2238806	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16666667	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15296000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	13271000	shares
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	395526	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	16886	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	177642	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	70694	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	232113	usd
	bmmj	Total Of Revanue TotalOfRevanue	-7765594	usd
	bmmj	Commision Interest Rate CommisionInterestRate	0.10	pure
	us-gaap	Interest Paid Net InterestPaidNet	206440	usd
	us-gaap	Interest Paid Net InterestPaidNet	663433	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5677	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	15171	usd
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16666667	shares
CY2022Q4	us-gaap	Business Acquisition Pro Forma Information Description BusinessAcquisitionProFormaInformationDescription	The Company entered into a three-year strategic advisory services agreement with Bengal Capital dated 5 January 2023 (“Bengal Advisory Agreement”). The Company shall pay Bengal Capital $240,000 on each anniversary, of which $60,000 is to be paid in cash and $180,000 is to be paid in cash, common stock, or warrants to purchase shares of the Company’s common stock, in such proportions as are determined by the Company. In February 2024, the Company settled the annual advisory fees of $240,000 accrued as of January 5, 2024, of which $60,000 was paid in cash and $180,000 was paid by issuing 2,700,393 common shares (Note 16). The Company has accrued $80,000 under this agreement as of 30 April 2024. In addition, if the Company successfully obtains a cultivation license in New Jersey during the term of the Bengal Advisory Agreement, the Company will owe a fee of $1,000,000, which will be payable in the form of the Company’s common stock or a warrant to purchase shares of the Company’s common stock, in either case as requested by Bengal Capital. As of 30 April 2024, no license has been obtained and therefore the related fee has not been paid or accrued
CY2023Q1	us-gaap	Business Acquisition Pro Forma Information Description BusinessAcquisitionProFormaInformationDescription	the Company entered into an agreement with John Kim, our consultant in the State of Illinois for a two-year services related to licensing process for a total payment of $86,500 payable in tranches until 10 June 2023, as well as $15,000 per month to three designated individuals for two (2) years ending on 31 December 2024, and $5,000 per month to one additional individual for six (6) months ending 30 June 2023 for an aggregate total of $476,500
	bmmj	Payments To Committed Payments PaymentsToCommittedPayments	733150	usd
CY2021Q3	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	0.85	pure
CY2024Q2	us-gaap	Deposits Deposits	1035026	usd
CY2023Q3	us-gaap	Deposits Deposits	72617	usd
CY2024Q2	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	80989	usd
CY2023Q2	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	3141358	usd
	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	2662441	usd
	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	9648988	usd
CY2024Q2	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	24969	usd
CY2023Q2	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	2990602	usd
	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	2354957	usd
	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	9092205	usd
CY2024Q2	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	56020	usd
CY2023Q2	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	150756	usd
	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	307484	usd
	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	556783	usd
CY2024Q2	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	141897	usd
CY2023Q2	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	496144	usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	800434	usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	2100215	usd
CY2024Q2	us-gaap	Disposal Group Including Discontinued Operation Other Income DisposalGroupIncludingDiscontinuedOperationOtherIncome	67	usd
CY2023Q2	us-gaap	Disposal Group Including Discontinued Operation Other Income DisposalGroupIncludingDiscontinuedOperationOtherIncome	945291	usd
	us-gaap	Disposal Group Including Discontinued Operation Other Income DisposalGroupIncludingDiscontinuedOperationOtherIncome	581350	usd
	us-gaap	Disposal Group Including Discontinued Operation Other Income DisposalGroupIncludingDiscontinuedOperationOtherIncome	944462	usd
CY2024Q2	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-141964	usd
CY2023Q2	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-1441435	usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-1381784	usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-3044677	usd
CY2024Q2	us-gaap	Discontinued Operation Provision For Loss Gain On Disposal Before Income Tax DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax	-85944	usd
CY2023Q2	us-gaap	Discontinued Operation Provision For Loss Gain On Disposal Before Income Tax DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax	-1290679	usd
	us-gaap	Discontinued Operation Provision For Loss Gain On Disposal Before Income Tax DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax	-1074300	usd
	us-gaap	Discontinued Operation Provision For Loss Gain On Disposal Before Income Tax DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax	-2487894	usd
CY2024Q2	us-gaap	Discontinued Operation Tax Expense Benefit From Provision For Gain Loss On Disposal DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal	97455	usd
CY2023Q2	us-gaap	Discontinued Operation Tax Expense Benefit From Provision For Gain Loss On Disposal DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal	-489630	usd
	us-gaap	Discontinued Operation Tax Expense Benefit From Provision For Gain Loss On Disposal DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal	-50329	usd
	us-gaap	Discontinued Operation Tax Expense Benefit From Provision For Gain Loss On Disposal DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal	-988820	usd
CY2024Q2	us-gaap	Discontinued Operation Provision For Loss Gain On Disposal Net Of Tax DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax	11511	usd
CY2023Q2	us-gaap	Discontinued Operation Provision For Loss Gain On Disposal Net Of Tax DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax	-1780309	usd
	us-gaap	Discontinued Operation Provision For Loss Gain On Disposal Net Of Tax DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax	-1124629	usd
	us-gaap	Discontinued Operation Provision For Loss Gain On Disposal Net Of Tax DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax	-3476714	usd
CY2024Q2	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	13514	usd
CY2023Q3	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	215622	usd
CY2024Q2	us-gaap	Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet	17319	usd
CY2023Q3	us-gaap	Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet	564392	usd
CY2024Q2	us-gaap	Accrued Fees And Other Revenue Receivable AccruedFeesAndOtherRevenueReceivable	0	usd
CY2023Q3	us-gaap	Accrued Fees And Other Revenue Receivable AccruedFeesAndOtherRevenueReceivable	20000	usd
CY2024Q2	us-gaap	Disposal Group Including Discontinued Operation Prepaid And Other Assets Current DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent	16251	usd
CY2023Q3	us-gaap	Disposal Group Including Discontinued Operation Prepaid And Other Assets Current DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent	332814	usd
CY2024Q2	us-gaap	Disposal Group Including Discontinued Operation Inventory Current DisposalGroupIncludingDiscontinuedOperationInventoryCurrent	156240	usd
CY2023Q3	us-gaap	Disposal Group Including Discontinued Operation Inventory Current DisposalGroupIncludingDiscontinuedOperationInventoryCurrent	1609521	usd
CY2024Q2	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment Current DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent	585936	usd
CY2023Q3	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment Current DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent	1143818	usd
CY2024Q2	bmmj	Disposal Group Including Discontinued Operation Operating Lease Right Of Use Asset DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset	177575	usd
CY2023Q3	bmmj	Disposal Group Including Discontinued Operation Operating Lease Right Of Use Asset DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset	356748	usd
CY2024Q2	bmmj	Disposal Group Including Discontinued Operation Brand And Licenses Net DisposalGroupIncludingDiscontinuedOperationBrandAndLicensesNet	0	usd
CY2023Q3	bmmj	Disposal Group Including Discontinued Operation Brand And Licenses Net DisposalGroupIncludingDiscontinuedOperationBrandAndLicensesNet	2047295	usd
CY2024Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	966835	usd
CY2023Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	6290210	usd
CY2024Q2	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities	2006371	usd
CY2023Q3	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities	479619	usd
CY2024Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	usd
CY2023Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	239434	usd
CY2024Q2	us-gaap	Disposal Group Including Discontinued Operation Other Liabilities DisposalGroupIncludingDiscontinuedOperationOtherLiabilities	182252	usd
CY2023Q3	us-gaap	Disposal Group Including Discontinued Operation Other Liabilities DisposalGroupIncludingDiscontinuedOperationOtherLiabilities	1541900	usd
CY2024Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	2188623	usd
CY2023Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	2260953	usd
CY2023Q3	bmmj	Cost Of Purchased Paid CostOfPurchasedPaid	2000000	usd
CY2023Q3	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	1000000	usd
CY2024Q1	bmmj	Cost Of Purchased Paid CostOfPurchasedPaid	2000000	usd
	bmmj	Description Of Letter Agreement DescriptionOfLetterAgreement	The purchase price of US$2,000,000 consists of: (i) a cash deposit of US$250,000 (paid); (ii) US$750,000 in cash to be paid within six months of receipt of regulatory approval by the Nevada Cannabis Compliance Board, which cash payment will be covered by a personal guarantee of an affiliate of Vegas Brazil; and (iii) a secured promissory note in the amount of US$1,000,000 (the "Note") to be delivered by Vegas Brazil to DEP on the closing date, and which Note will be personally guaranteed by an affiliate of Vegas Brazil. The Note shall bear interest at the applicable federal rate as of the closing date and the Note will be paid in six (6) equal monthly payments with the first payment occurring on the seven (7) month anniversary of the closing date
CY2024Q2	us-gaap	Deposit Liabilities Reclassified As Loans Receivable1 DepositLiabilitiesReclassifiedAsLoansReceivable1	1750000	usd
CY2024Q2	us-gaap	Cash Cash	750000	usd
	us-gaap	Notes Issued1 NotesIssued1	1000000	usd
	bmmj	Descriptionofmanufacturing Equipment Lease Agreement DescriptionofmanufacturingEquipmentLeaseAgreement	The term of the agreement commenced on 21 July 2023 and received a deposit of $20,000 that will be applied to the last monthly rent payment. For the first year of the lease, the rent is $20,000 per month. The lease can be terminated by either party with a 90-day written notice, or 30-day notice with cause
CY2023Q4	us-gaap	Cost Of Services Catering CostOfServicesCatering	7975000	usd
CY2023Q4	us-gaap	Payments For Deposits PaymentsForDeposits	250000	usd
	bmmj	Cost Of Purchased Paid CostOfPurchasedPaid	100000	usd
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	100000	usd
	us-gaap	Payments For Rent PaymentsForRent	2500000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	7330000	usd
CY2023	us-gaap	Sales Type Lease Impairment Loss SalesTypeLeaseImpairmentLoss	944015	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	388351	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	449397	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1751866	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1196343	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	6236092	usd
	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	706210	usd
	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	107001	usd

Files In Submission

Name	View Source	Status
0001640334-24-000994-index-headers.html	Edgar Link	pending
0001640334-24-000994-index.html	Edgar Link	pending
0001640334-24-000994.txt	Edgar Link	pending
0001640334-24-000994-xbrl.zip	Edgar Link	pending
bmmj-20240430.xsd	Edgar Link	pending
bmmj_10q.htm	Edgar Link	pending
bmmj_ex311.htm	Edgar Link	pending
bmmj_ex312.htm	Edgar Link	pending
bmmj_ex321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
bmmj-20240430_pre.xml	Edgar Link	unprocessable
bmmj-20240430_lab.xml	Edgar Link	unprocessable
bmmj_10q_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bmmj-20240430_cal.xml	Edgar Link	unprocessable
bmmj-20240430_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BMMJ
BODY & MIND INC. Stock $bmmj

2024 Q2 Form 10-Q Financial Statement

#000164033424000994 Filed on June 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BMMJ BODY & MIND INC. Stock $bmmj

2024 Q2 Form 10-Q Financial Statement

#000164033424000994 Filed on June 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BMMJ
BODY & MIND INC. Stock $bmmj